The CST strategic plan sets our out goals and objects for 2024 to 2029. Cancer Symptom Trials (CST) is playing a crucial role in addressing a significant gap in cancer care by focusing on symptom management and supportive care for people with cancer.
As the number of Australians diagnosed with cancer continues to rise and survival rates lengthen, the need for optimised symptom management and supportive care has become more important than ever.
The effects of cancer and its treatments often result in symptoms that have a profound impact on quality of life, relationships, traditional and cultural roles within the family and society, daily functioning, financial needs, and the ability to receive or continue with treatments. These challenges not only affect people with cancer but also place a significant burden on their caregivers.
Our vision
Everyone impacted by cancer will have access to evidence-based cancer symptom management that improves their quality of life.
Our purpose
To facilitate high-quality, inclusive clinical trials and interdisciplinary research in cancer symptom management, supportive care, and survivorship across all cancer types.
Strategic directions
In advancing our vision and actively fulfilling our purpose, our strategic directions will drive innovation and impact by embedding consumer and community involvement, strengthening research capability and leadership, nurturing collaborative partnerships, and translating research into practice for meaningful change.